NDVRX
Price
$16.51
Change
-$0.65 (-3.79%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

NDVRX vs VSIAX

Header iconNDVRX vs VSIAX Comparison
Open Charts NDVRX vs VSIAXBanner chart's image
MFS New Discovery Value R1
Price$16.51
Change-$0.65 (-3.79%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
NDVRX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NDVRX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDVRX is a StrongSell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. NDVRX (3.44B). VSIAX pays higher dividends than NDVRX: VSIAX (2.01) vs NDVRX (0.35). NDVRX was incepted earlier than VSIAX: NDVRX (14 years) vs VSIAX (13 years). NDVRX is a more actively managed with annual turnover of: 30.00 vs. VSIAX (16.00). NDVRX has a lower initial minimum investment than VSIAX: NDVRX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. NDVRX (7.75). VSIAX return over 5 years is better than : 52.83 vs. NDVRX (11.34).
NDVRXVSIAXNDVRX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD6.49115.03143%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.44B63B5%
Annual Yield % from dividends0.352.0118%
Returns for 1 year7.7516.2348%
Returns for 3 years-4.4220.67-21%
Returns for 5 years11.3452.8321%
Returns for 10 years41.50105.6539%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics